Login / Signup

Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: The ULTIMATE-DAPT trial.

Pascal VranckxMarco Valgimigli
Published in: European heart journal. Acute cardiovascular care (2024)
Keyphrases
  • antiplatelet therapy
  • acute coronary syndrome
  • percutaneous coronary intervention
  • clinical trial
  • phase iii
  • coronary artery disease
  • phase ii
  • atrial fibrillation
  • adverse drug